Skip to Main Content

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death

Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
Implantable cardioverter-defibrillators (ICDs) are battery-powered implantable devices that monitor heart rhythm and deliver therapy in the form of either electric shock or antitachycardia pacing (ATP) when a life-threatening ventricular arrhythmia is detected. ICDs have been used in patients who survived sustained ventricular arrhythmias to prevent sudden cardiac death (SCD). In recent years, ICDs have also been implanted for primary prevention (prevention of SCD in a patient who has not had yet had sustained ventricular tachyarrhythmia but has risk factors for it). ICDs may also include cardiac resynchronization therapy (CRT) for additional treatment of heart failure in patients with dyssynchronous ventricles.

Download technology assessment [PDF, 1MB]

Download appendices [PDF, 1MB]
4